Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;41(9):376-379.
doi: 10.1016/j.urolonc.2023.04.014. Epub 2023 May 10.

New technology in prostate cancer and financial toxicity

Avinash Maganty  1 , Brent K Hollenbeck  2
Affiliations
Review

New technology in prostate cancer and financial toxicity

Avinash Maganty et al. Urol Oncol. 2023 Sep.

Abstract

The management of prostate cancer has significantly evolved over the last few decades with the emergence of new diagnostic and treatment technologies, which are typically more expensive than the previous alternatives. However, decision-making regarding which diagnostics and treatment to pursue is often influenced by perceived benefits, adverse effects, and physician recommendations, without considering the financial liability borne by patients. New technologies may exacerbate financial toxicity by replacing less costly alternatives, promoting unrealistic expectations, and expanding treatment to those who would have previously gone untreated. More judicious use of technologies with an understanding of the contexts in which they are most beneficial may help prevent avoidable financial toxicity to patients.

Keywords: Financial toxicity; New technology; Prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no conflicts of interest to declare.

References

    1. Sheetz KH, Claflin J, Dimick JB. Trends in the Adoption of Robotic Surgery for Common Surgical Procedures. JAMA Network Open. 2020;3(1):e1918911. doi: 10.1001/jamanetworkopen.2019.18911 - DOI - PMC - PubMed
    1. Royce TJ, Efstathiou JA. Proton therapy for prostate cancer: A review of the rationale, evidence, and current state. Urologic Oncology: Seminars and Original Investigations. 2019;37(9):628–636. doi: 10.1016/j.urolonc.2018.11.012 - DOI - PubMed
    1. Mahase SS, D’Angelo D, Kang J, Hu JC, Barbieri CE, Nagar H. Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States. JAMA Netw Open. 2020;3(2):e1920471. doi: 10.1001/jamanetworkopen.2019.20471 - DOI - PMC - PubMed
    1. Fizazi K, Tran N, Fein L, et al. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. New England Journal of Medicine. 2017;377(4):352–360. doi: 10.1056/NEJMoa1704174 - DOI - PubMed
    1. Research C for DE and. FDA approves second PSMA-targeted PET imaging drug for men with prostate cancer. FDA. Published online September 30, 2021. Accessed October 13, 2022. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-second-ps...

Publication types